Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes

(MedPage Today) -- The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with lecanemab (Leqembi) in real-world clinical practice were consistent with the known safety profile of...
Source
MedPage Today
Opens original article in a new tab



